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ABSTRACT 
Background: As prenatal screening for sexually transmitted infections and treatment of infected pregnant women is not 
routinely performed in Iran and prevalence of two sexually transmitted pathogens, Chlamydia trachomatis and Mycoplasma 
genitalium, in Sabzevar (east of Iran) is unknown, we decided to perform this prospective study. 
Methods: One hundred ninety-six urine specimens of pregnant women attending the specialized maternity hospital of the 
city were collected and tested by duplex PCR.
Results: A total of 31 specimens were positive (15.81%) (27 Chlamydia trachomatis isolates, 13.77%; and 2 Mycoplasma 
genitalium isolates, 1.02%). Co-infection with both species was detected in 2 specimens (1.02%). A significant correlation 
was found between preterm labor and infection (P-value ≤ 0.05).
Conclusion: The present study shows high prevalence of Chlamydial infections in comparison with Mycoplasma genitalium 
in this region. Further studies with larger sample size and more focused on different groups at risk are needed for a movement 
towards prevention and control of sexually transmitted infections (STIs).
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INTRODUCTION
There  are  more  than  30  different  sexually 
transmissible agents and the most common treatable 
and preventable of them is Chlamydia trachomatis. 
Rapid  detection  of  Chlamydial  infections  in  the 
medical laboratory is very important. Epidemiologic 
studies have indicated that the most serious sequela 
occur  in  women  are  pelvic  inflammatory  disease 
(infection  in  the  fallopian  tubes)  and  ectopic 
pregnancy (pregnancy in the tubes) (1). In addition, 
several reports have suggested that untreated maternal 
cervical  chlamydial  infection  increases  the  risk  of 
preterm  delivery,  premature  rupture  of  membranes 
(PROM), and prenatal mortality or stillbirth (2). In 
newborns, infection can occur as a result of prenatal 
exposure; approximately 65% of babies born from 
infected  mothers  become  infected  during  vaginal 
delivery.  Infections  caused  by  C.  trachomatis  are 
particularly difficult to confine as a high proportion 
of these infections are asymptomatic, thus making 
part of the population (those not tested) a reservoir 
for further transmission (3).
Mycoplasma  genitalium  (M.  genitalium)  which 
was discovered in the early 1980s has proved itself as 
a significant pathogen. It is similar to C. trachomatis 
in several respects such as preference for the genital 
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tract, mode of transmission, making various adverse 
gynecologic and reproductive events and cervicitis 
(4). It has been implicated as an etiological agent of 
pelvic inflammatory disease (PID) independent of C. 
trachomatis and Neisseria gonorrhoeae (5). Also in 
one study, an association has been reported between 
M. genitalium and preterm delivery (6).
Screening of C. trachomatis with cell culture as a 
gold standard is very difficult and requires specimens 
from  urogenital  swabs,  which  are  unacceptable  to 
many  people.  Urine  samples  have  cytotoxic  effect 
and are not suitable for culture. Other routine tests for 
Chlamydia, such as enzyme immunoassays, have low 
sensitivity  in  asymptomatic  individuals.  Detection 
of M. genitalium by the culture method is also very 
time-consuming and requires up to 8 weeks for this 
microorganism whereas the nucleic acid amplification 
techniques can detect infectious agents in less than 8 
hours (7). 
Because  of  difficulties  in  cultivation  of  these 
fastidious organisms, some 15 years ago, a great deal 
of research has led to the development and evaluation 
of  sensitive  and  specific  diagnostic  tests  based  on 
nucleic  acid  amplification  tests.  The  important 
aspect of these assays was their capacity to be used 
on non-invasive specimens such as first void urine 
(FVU),  which  can  be  self-collected.  Therefore  it 
facilitates larger investigations on prevalence in many 
populations (8).
Nucleic  acid  amplification  tests  showed  >  95% 
sensitivity  and  specificity  for  detection  of  M. 
genitalium and C. trachomatis from urine samples 
(9). More recently, different PCR methods have been 
developed to detect STI-causing organisms. One of 
these methods is multiplex PCR (mPCR), which is a 
single step method that employs one tube  containing 
PCR mixture and permits the simultaneous detection 
of more than one organism. This method has been used 
to detect multiple bacterial STIs in clinical specimens 
(10). This  mPCR  assay  will  be  a  more  time-  and 
cost-efficient diagnostic tool than the other currently 
employed  techniques.  Specificity  and  sensitivity 
of  this  method  for  detection  of  C.  trachomatis 
and M. genitalium were estimated to be 100% and 
98.9%, respectively (11). The aim of this study was 
to investigate the prevalence of C. trachomatis and 
M. genitalium, and related risk factors in pregnant 
women for the first time in Sabzevar city.
MATERIALS  AND  METHODS
One hundred ninety-six urine samples of pregnant 
women (< 50 years old; in second or third trimesters 
of pregnancy) attending in the only maternity hospital 
(Mobini  Martyr  Hospital)  of  Sabzevar  city,  from 
September 2010 to February 2011 were screened for 
eligibility.  Participants  were  ineligible  if  they  had 
antibiotic  use  in  the  last  3  weeks,  kidney  disease, 
catheter  usage,  cognitive  impairment,  and  illness 
severity that precluded study interview (12).
Two  trained  research  assistants  obtained  the 
following information from each participant through 
a specific questionnaire and face-to-face individual 
interview: socio-demographic data (age, education, 
and residence), current history of clinical signs and 
urogenital symptoms (preterm labor, dysuria, urinary 
urgency, urinary frequency, vaginal discharge, vaginal 
itching) and sexual history (history of STIs, history of 
abortion, history of preterm delivery).
The research ethics board at Sabzevar University of 
Medical Sciences approved this research project and 
all participants signed a consent form.
10 ml of First Void Urine (FVU) were collected 
at  least  two  hours  after  last  urination  in  a  sterile 
container. Samples were not frozen before testing but 
maintained at 4°C for one night in order to decrease 
inhibitors in urine (13). Finally, samples on ice were 
transported to the  research laboratory. Immediately 
samples were centrifuged in 4°C (6000 g for 30min) 
and pellets were washed with PBS (Phosphate Buffer 
Saline) twice and prepared for DNA extraction by 
DNG-Plus kit (Cinnagen, Tehran, Iran) according to 
the manufacturer’s protocol. Extracted DNAs were 
stored at -70°C (14).
Species                                                                                                              Sequences
C. trachomatis
Forward   5´- CTAGGCGTTTGTACTCCGTCA -3´
Reverse      5´- TCCTCAGGAGTTTATGCACT -3´
200bp
M. genitalium Forward   5´-AGTTGATGAAACCTTAACCCCTTG-3´
Reverse      5´- CATTACCAGTTAAACCAAAGCCT -3´
346 bp
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PCR Reaction. Table 1 shows the sequences of 
primers used to amplify a specific 200 bp fragment of 
the Orf 8 gene of C. trachomatis and primers were used 
for a specific 346 bp fragment of the conserved part 
of MgPa adhesion gene  (MG192) of M. genitalium 
(15).
Initially,  to  establish  the  conditions  for  Duplex 
PCR, we set up uniplex PCR using positive control 
DNA from C.trachomatis serovar L2 type strain 434/
Bu (ATCC VR-902B) and M. genitalium type strain 
G37  (ATCC  35350). Amplification  reactions  were 
performed in a volume of 20 μl containing 1 μl of 
extracted DNA. The reaction involved one cycle at 
94°C for 5 min, followed by 30 cycles of denaturation 
at 94°C for 30 sec, annealing at 54°C or 56°C for 35 
sec, and extension at 72°C for 30 sec followed by 
one last cycle at 72°C for 8 min. The reactions were 
performed on a PCR system (Techne, UK). 
Subsequently,  duplex  PCR  conditions  were 
established using a mixture of DNA from both control 
bacterial  strains.  The  40  μl  Duplex  PCR  reaction 
mixture consisted of 1 μl from each extracted DNAs, 
4 µl of the master mix solution, 0.5 µl of each specific 
oligonucleotide primer.
The reaction for the uniplex PCR was the same 
except that annealing temperature was 55°C. Once 
the Duplex PCR conditions had been optimized, the 
196 FVU samples were subjected to Duplex PCR. In 
addition, negative controls lacking DNA and positive 
controls  consisting  300  ng  of  genomic DNA  from 
each bacterial strains were tested. The PCR products 
were analyzed by electrophoresis in the 0.5% TBE 
buffer through 1% agarose gel, stained with ethidium 
bromide,  and  DNA  bands visualized using  a UV 
transilluminator.
The collected data were entered into a computer 
using SPSS, version 15. The statistical relationship 
between the risk factors and infection were assessed 
using the chi-squared test.
RESULTS
We  recruited  196  pregnant  women  between 
September 2010 and February 2011 and 10 women 
(5% of total subjects) inevitably were excluded from 
the study.  Subjects ranged in age from 17–45 years 
(mean 31.0 years); and  a high proportion of women 
were  below  30  years  old  which  represented  about 
66.8% of all cases (Table 2). In this study, 74.4% 
of participants lived in the city and 65.8% of them 
did not have children. Also, 37.2% had at least one 
or  more  symptoms  referable  to  the  genito-urinary 
tract at time of interview. Vaginal discharge, urinary 
frequency and vaginal itching were common current 
clinical symptoms in all pregnant women. 
A  statistical  association  was  seen  significantly 
between  preterm  labor  and  infection  in  this  study 
(P-value  ≤  0.05).  Also  data  analyses  suggest  a 
possible positive correlation of infection with history of 
abortion in pregnant women (P value ≤ 0.1). Of 196 
Risk factors  Infected % Not-infected % Total P-value
Age                                                                                                                                    NS       
years old 30 > 22 11.2% 109 55.6% 131
years old 30 ≤ 9 4.5% 56 28.5% 65
Education                                                                                                                                     NS
Illiterate/High school 24 12.2% 144 73.4% 168
Diploma/university degree 7 3.5% 21 10.7% 28
Symptoms                                                                                                                                     NS
Yes 11 5.6% 62 31.6% 73
No 20 10.2% 103 52.5% 123
Preterm Labor                                                                                                                                 P ≤ 0.05
Yes 4 2.0% 52 26.5% 56
No 27 13.7% 113 57.6% 140
History of STIs                                                                                                                                     NS
Yes 5 2.5% 19 9.6% 24
No 26 13.2% 146 74.4% 172
History of Abortion                                                                                                                                  P ≤ 0.1
Yes 3 1.5% 37 18.8% 40
No 28 14.2% 128 65.3% 156
Table 2. Statistical analysis of important variables in pregnant women.
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women, 31 (15.81%) were positive in PCR test. C. 
trachomatis was detected in 27 samples (13.77%) and 
M. genitalium was positive in two samples (1.02%). 
Also co-infection was seen in two samples (1.02%).
Table  2  illustrates  statistical  analysis  results  of 
important variables in this study.
DISCUSSION
There  were  several  studies  conducted  in  Iran 
that  reported  the  prevalence  of  C.  trachomatis 
to be from 2% to 11%. Only in one study 5.2% of 
pregnant women were reported to be infected with M. 
genitalium. It is worth noting that the diagnostic tests 
varied in the different studies and could contribute to 
the differences in the reported prevalence rates. Many 
studies  have  found  that  nucleic  acid  amplification 
tests are sufficiently sensitive to detect C. trachomatis 
and  M.  genitalium  in  first-void  urine  of  women. 
Sensitivities have exceeded 95% in most studies when 
compared to detection with non-culture methods of 
endocervical specimens as a standard, while at the 
same time preserving high specificities (16).
The  prevalence  of  C.  trachomatis  reported  in 
this study (14.79%) is high in comparison with the 
moderate rates reported by other studies in Tehran, 
Iran (11.1% and 11.2% respectively) in similar study 
subjects and settings (17, 18). In two different studies 
conducted with Direct Immunoflourescent assay and 
ELISA  consecutively  in  Bandarabbas  and  Ahvaz, 
south  &  south-west  of  Iran,  the  prevalence  of  C. 
trachomatis infection were reported to be 5.2% and 
10%  in pregnant women respectively (19, 20). In 
addition, two other studies from Tehran with similar 
methods  (Direct  Immunoflourescent  and  ELISA) 
report  2.7%  and  2.9%  Chlamydial  prevalence  in 
pregnant women (21, 22). C. trachomatis prevalence 
differs by treatment practices in different areas, but 
it seems that use of low sensitivity methods are the 
main reason for significant difference in prevalence 
rate reported from Tehran. 
Depending  on  health  status,  the  existence  of 
symptoms  and  risky  behavior  of  individuals,  the 
prevalence of STIs in women differ from one country 
to another. Numerous surveys have been carried out 
to study the prevalence of C. trachomatis infection 
and risk factors among pregnant women or women 
attending antenatal clinics. C. trachomatis infection 
rate in our study is moderate in comparison to those 
found  in  several  other  countries:  10.1%  in  China, 
10.5% in Saudi Arabia, 12.1% in Scotland, 35% in 
India (23-26). 
In this study, M. genitalium was detected in 2.04% 
of participants, which illustrates a low percentage of 
occurrences in this region. In one study, performed by 
duplex PCR assay for simultaneously detection of M. 
genitalium and Ureaplasma Urealyticum in pregnant 
and non pregnant women of Tehran, the prevalence 
of M. genitalium was 5.2% (11/210) in total (27). The 
difference in the results of these two studies may be 
contributed to the type of subjects (pregnant vs. non-
pregnant) and the sample type (urine vs. swabs).  Also 
prevalence of M. genitalium in this study is similar to 
one study in Canada, with 3.6% infection in pregnant 
women (28).
Previous  epidemiological  investigations  for  C. 
trachomatis in pregnant women have revealed various 
associated risk factors for infection including age (in 
particular  18-27  years)  and  socio-economic  status 
factors like urban residency or low-income (29). In 
this study, 75.8% of pregnant women with positive 
test results were less than 30 years old and 72.4% of 
infected women lived in the city, which confirmed 
results  of  previous  research.  Also  in  our  study,  a 
significantly higher detection rate of C. trachomatis 
infection  was observed among primigravida (82.7%) 
compared to, multigravida (17.3%) and is similar to 
results of one study in Japan that demonstrated the 
prevalence of C. trachomatis was significantly higher 
among this  group ( primigravida) of pregnant women 
(30). 
Based on several studies, one of the leading causes 
of prenatal mortality is prematurity. Asymptomatic 
bacteriuria,  gonococcal  cervicitis  and  bacterial 
vaginosis  are  strongly  associated  with  preterm 
delivery, but the role of C. trachomatis was less clear 
(31).  Recently,  new  studies  report  that  infections 
with C. trachomatis are associated with premature 
delivery in pregnancy and our findings confirmed this 
(32, 33).
In  many  studies,  researchers  have  indicated  C. 
trachomatis  and  infection  caused  by  this  microorganism 
as a risk factor in abortion, prenatal mortality and 
stillbirth  (34).  Although  a  weak  association  was 
seen in this study (Table 2), which confirmed this 
relationship, more studies with larger sample size in 
longer follow-ups are needed to investigate this factor 
during pregnancy and its outcome.
The rate of complications following a C. trachomatis 
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cost-effectiveness in screening programs. Health care 
costs after a C. trachomatis infection in the United 
States have been estimated to exceed US $2 billion 
per year (35).
The Iranian health care system needs to revise the 
antenatal care offered and factors that encourage the 
utilization of antenatal services, such as offering the 
services free of charge, providing incentives, health 
promotion and adequate postnatal services.
CONCLUSION
The prevalence obtained in this study is relatively 
high. In our region (east of Iran), there are no data 
about C. trachomatis and M. genitalium in pregnant 
women  and  this  is  the  first  study  conducted  in 
Sabzevar city. However, further studies with larger 
sample size and more focused on different groups at 
risk are needed for movement towards prevention and 
control of STIs.
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